Scinai Immunotherapeutics Shares Fall Following $4M Financing Agreement

Key Facts

Scinai Immunotherapeutics announced a new $4 million financing deal. Seeking Alpha reported that the company's shares tumbled following the announcement of the financing details, which involve securities purchase and warrant inducement agreements with an existing institutional investor.

SCNI closed at $1.23 on October 13, 2026, with the stock recording a day high of $1.76 and a day low of $1.14. The price action followed the disclosure of a private placement including 2.46 million American Depositary Shares (ADSs) or pre-funded warrants.